Organisation paid for research Program year 2025 Source: CMS Open Payments

Palmetto Pediatrics

Neither a doctor nor a teaching hospital

Research payments

$288,524

121 payments

Through program year 2025, Palmetto Pediatrics is reported as receiving $288,524 in research payments, across 121 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$3,318	2
2024	Research	$119	1
2023	Research	$30,772	13
2022	Research	$181	2
2021	Research	$12,495	7
2020	Research	$113,121	42
2019	Research	$128,518	54

Breakdown

Who paid Research payments · program years 2019–2025

GlaxoSmithKline, LLC. $165,700 107 payments
AstraZeneca Pharmaceuticals LP $106,670 8 payments
AstraZeneca UK Limited $13,154 4 payments
Sanofi Pasteur Inc. $3,000 2 payments

Studies the money was for Research payments · program years 2019–2025

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY) $115,641 10 payments
Menb Rec 2Nd Gen-023 (V72_57) $112,438 75 payments
Phase Iiib, Observer-Blind, Randomized, Placebo-Controlled, Multi-Cent $22,103 20 payments
A Phase III, Randomized, Controlled, Observer-Blind Study to Evaluate $13,270 3 payments
Study name not reported $5,819 5 payments
Rota-081 $5,473 1 payment
Rota-090 $5,153 1 payment
MEDI8897 RSV mAb-D5290C00003 Phase 2 / 2b Clinical Trial $4,183 2 payments
MET41 A Randomized Study to Describe the Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers $3,000 2 payments
A Phase 3, Open-Label, Randomized, Controlled, Multi Country Study to $869 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.